Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A0STSQ8
Mon, 05.02.2024
M1 Kliniken AG
The two members of the Management Board of M1 Kliniken AG, Mr Attila Strauss and Mr Kilian Brenske, acquired a total of 1.5 million shares in the company from MPH Health Care AG on 2 February 2024. The Co-CEOs justify the share purchase with their confidence in the long-term growth prospects of M1 Kliniken AG and the desire to participate even more [ … ]
Mon, 22.01.2024
M1 Kliniken AG
Invitation to the virtual AlsterResearch Healthcare Pop-Up Conferenceon 23 January 2024 at 1:30 pm
As part of the AlsterResearch Healthcare Pop-Up Conference, we cordially invite you to our virtual roundtable on Tuesday, 23 January 2024 at 13:30 (CET). Attila Strauss, Co-CEO of M1 Kliniken AG, and Kilian Brenske, Co-CEO of M1 Kliniken AG, will give [ … ]
Fri, 24.11.2023
M1 Kliniken AG
M1 Kliniken AG Acquires Online Pharmacy and Secures Long-Term Procurement Advantages
Increasing value creation and margin improvement, as well as ensuring the supply of aesthetic pharmaceuticals to medical treatment centers through the acquisition of a Dutch online pharmacy.
Berlin, November 24, 2023 – By acquiring the German Nutri Care GmbH and [ … ]
Thu, 16.11.2023
M1 Kliniken AG
M1 Kliniken AG publishes figures for the third quarter 2023: Further strong growth and doubling of the operating result
Group sales increase by over 10% to EUR 236.6 million in the first nine months of the 2023 financial year (previous year: EUR 214.2 million).
Group EBITDA increases by over 55% from EUR 10.9 million to EUR 16.9 million.
[ … ]
Fri, 01.09.2023
M1 Kliniken AG
M1 Kliniken AG: Market leader for beauty medicine in Germany opens up in the 9th foreign market and prepares market entry in the USA
20th Location outside Germany opened in Bucharest, Romania
Break-even expected for foreign locations within the next 12 months
Subsidiary established in the USA: Market entry into the world's largest market for [ … ]
Thu, 31.08.2023
M1 Kliniken AG
M1 Kliniken AG publishes figures for the first half year 2023:
Further growth and disproportionate increase in operating result.
Group revenue increases by around 9% to EUR 150.8 million in the first half of 2023 (previous year: EUR 138.7 million)
Group EBIT increases by over 60 % to EUR 7.3 million (previous year: EUR 4.5 million)
Beaut [ … ]
Wed, 31.05.2023
M1 Kliniken AG
M1 Kliniken AG publishes Q1 figures 2023:
Strong growth and disproportionate increase in operating result.
Group revenue rises by 21% to EUR 76.8 million
Group EBITDA amounts to EUR 5.3 million (previous year: EUR 4.2 million); EBIT amounts to EUR 4.0 million (previous year: EUR 2.8 million)
Beauty segment: sales increase of more than 50% [ … ]
Wed, 31.05.2023
M1 Kliniken AG
M1 Kliniken AG publishes Q1 figures 2023:
Strong growth and disproportionate increase in operating result.
Group revenue rises by 21% to EUR 76.8 million
Group EBITDA amounts to EUR 5.3 million (previous year: EUR 4.2 million); EBIT amounts to EUR 4.0 million (previous year: EUR 2.8 million)
Beauty segment: sales increase of more than 50% [ … ]
Thu, 20.04.2023
M1 Kliniken AG
M1 Kliniken AG publishes preliminary figures for financial year 2022:
Profitable revenue growth in the Beauty segment of more than 14%; increase in EBIT margin in the Beauty segment from 9.8% to around 12%; Group equity rises to €143.1 million; free cash flow of €19.0 million.
Strong sales growth in the Beauty segment from €52.8 [ … ]
Thu, 20.04.2023
M1 Kliniken AG
M1 Kliniken AG publishes preliminary figures for financial year 2022:
Profitable revenue growth in the Beauty segment of more than 14%; increase in EBIT margin in the Beauty segment from 9.8% to around 12%; Group equity rises to €143.1 million; free cash flow of €19.0 million.
Strong sales growth in the Beauty segment from €52.8 [ … ]